Oryzon Genomics S.A. (BME:ORY)

Oryzon Genomics Revenue

Oryzon Genomics had revenue of $8.63M USD in the twelve months ending September 30, 2025, down -45.45% year-over-year. In the year 2024, Oryzon Genomics had annual revenue of $7.62M, down -51.43%.

• Revenue (ttm): $8.63M
• Revenue Growth: -45.45%
• P/S Ratio: 34.29
• Revenue / Employee: $183.70K
• Employees: 47
• Market Cap: 252.33M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.62M	-8.07M	-51.43%
Dec 31, 2023	15.69M	-1.09M	-6.50%
Dec 31, 2022	16.78M	4.70M	38.97%
Dec 31, 2021	12.07M	425.74K	3.66%
Dec 31, 2020	11.65M	112.98K	0.98%